RD2Rx was founded in 2012 with a focus on providing cost effective product development, regulatory, compliance, and other related services.
Over a short period our platform has developed and commercialized several products and added capabilities.
We specialize and focus on first to market or niche generic drug products and on improvements to existing products via the 505(b)(2) regulatory pathway.
In January 2017, we moved to a state of the art 20,000 sq. ft. facility to provide in house cGMP Analytical Services and Product Development Services.
Our facility is FDA registered and inspected, cGMP compliant, and DEA licensed (schedules 2 to 5).
In addition, our support operations in New Delhi, India provide a round the clock operation.
20,000 sq. ft. on a 3 acre campus.
On site UPS power back up and generator.
Fully temperature controlled.
Capacity to expand another 40,000 sq. ft.